Clinical and genetic characteristics of late-onset Stargardt's disease
- PMID: 22449572
- DOI: 10.1016/j.ophtha.2012.01.005
Clinical and genetic characteristics of late-onset Stargardt's disease
Abstract
Objective: To describe the genotype and phenotype of patients with a late-onset Stargardt's disease (STGD1).
Design: Retrospective case series.
Participants: Twenty-one unrelated STGD1 patients with an age at onset of ≥45 years and ≥1 rare variant in the ABCA4 gene.
Methods: Ophthalmologic examination, including best-corrected visual acuity (VA), Amsler grid testing, fundus photography, fluorescein angiography (FA), spectral-domain optical coherence tomography (OCT), fundus autofluorescence (FAF) imaging, full-field electroretinography (ERG), multifocal ERG, and central visual field testing. Analysis of the ABCA4 gene was performed using microarray analysis, sequencing, and multiplex ligation-dependent probe amplification. In addition, the PRPH2 and CFH genes were sequenced.
Main outcome measures: Age at onset, VA, fundus appearance, FA, FAF, and OCT findings; ABCA4 mutations; and genotype-phenotype correlation.
Results: The mean age at onset was 55 years (range, 45-72 years). Seven patients were diagnosed without visual symptoms (age range, 45-83 years). The VA was ≥20/40 in 24 eyes of 14 patients (59%) owing to foveal sparing. On ophthalmoscopy, late-onset STGD1 showed flavimaculatus flecks (15 patients), small flecks surrounding mottled foveal changes (3 patients), extensive chorioretinal atrophy (2 patients), or small yellowish spots in the macula (1 patient). The fundus flecks showed increased autofluorescence on FAF. The choroidal background fluorescence on FA was obscured in 16 patients (80%). We found a single heterozygous ABCA4 variant in 11 patients (52%), 2 compound heterozygous variants in 8 patients (38%), and a homozygous variant in 2 patients (10%). No PRPH2 or CFH mutations were detected.
Conclusions: Late-onset STGD1 is at the mild end of the spectrum of retinal dystrophies caused by ABCA4 mutations. The VA is frequently preserved in late-onset STGD1 patients owing to foveal sparing. This phenotype may be caused by 1 or 2 ABCA4 variants. The differential diagnosis between late-onset STGD1 and age-related macular degeneration may be challenging. A thorough clinical and genetic analysis makes a distinction possible, which is important for clinical and genetic counseling.
Financial disclosure(s): The authors have no proprietary or commercial interest in any of the materials discussed in this article.
Copyright © 2012 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Early-onset stargardt disease: phenotypic and genotypic characteristics.Ophthalmology. 2015 Feb;122(2):335-44. doi: 10.1016/j.ophtha.2014.08.032. Epub 2014 Oct 17. Ophthalmology. 2015. PMID: 25444351
-
Foveal sparing in Stargardt disease.Invest Ophthalmol Vis Sci. 2014 Oct 16;55(11):7467-78. doi: 10.1167/iovs.13-13825. Invest Ophthalmol Vis Sci. 2014. PMID: 25324290
-
Study of Late-Onset Stargardt Type 1 Disease: Characteristics, Genetics, and Progression.Ophthalmology. 2024 Jan;131(1):87-97. doi: 10.1016/j.ophtha.2023.08.011. Epub 2023 Aug 19. Ophthalmology. 2024. PMID: 37598860
-
Stargardt Disease.Adv Exp Med Biol. 2018;1085:139-151. doi: 10.1007/978-3-319-95046-4_27. Adv Exp Med Biol. 2018. PMID: 30578500 Review.
-
Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options.Br J Ophthalmol. 2017 Jan;101(1):25-30. doi: 10.1136/bjophthalmol-2016-308823. Epub 2016 Aug 4. Br J Ophthalmol. 2017. PMID: 27491360 Free PMC article. Review.
Cited by
-
Retinoic acid related orphan receptor α is a genetic modifier that rescues retinal degeneration in a mouse model of Stargardt disease and Dry AMD.Gene Ther. 2024 Jul;31(7-8):413-421. doi: 10.1038/s41434-024-00455-z. Epub 2024 May 16. Gene Ther. 2024. PMID: 38755404
-
The central retinal thickness and its related genotype in ABCA4-related retinopathy.Eye (Lond). 2024 May 13. doi: 10.1038/s41433-024-03104-2. Online ahead of print. Eye (Lond). 2024. PMID: 38740961
-
Recent Progress in Retinal Pigment Epithelium Cell-Based Therapy for Retinal Disease.Stem Cells Transl Med. 2024 Apr 15;13(4):317-331. doi: 10.1093/stcltm/szae004. Stem Cells Transl Med. 2024. PMID: 38394392 Free PMC article. Review.
-
Protein modeling and in silico analysis to assess pathogenicity of ABCA4 variants in patients with inherited retinal disease.Mol Vis. 2023 Oct 25;29:217-233. eCollection 2023. Mol Vis. 2023. PMID: 38222458 Free PMC article.
-
Multimodal imaging and deep learning in geographic atrophy secondary to age-related macular degeneration.Acta Ophthalmol. 2023 Dec;101(8):881-890. doi: 10.1111/aos.15796. Acta Ophthalmol. 2023. PMID: 37933610 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous